AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
companies in this sector in the United States:
Eli Lilly and Company
sales of $24.56 billion
of which 48%
was Human pharmaceutical products - Endocrin),
Teva Pharmaceutical Industries Limited
of which 49%
was North America), and
Bristol-Myers Squibb Company
of which 100%
During the year ended December of 2018, sales at
AstraZeneca PLC were $22.09 billion.
decrease of 1.7%
versus 2017, when the company's sales were $22.47 billion.